ea0070ep64 | Bone and Calcium | ECE2020
Figueiredo Ana
, Damasio Ines
, Cavaco Daniela
, Simões Helder
, Simões-Pereira Joana
, Leite Valeriano
Background: Malignant hypercalcemia (MH) occurs in up to 30% of patients who are diagnosed with cancery, being associated with later stages of the disease and poor prognosis. The physiopathological mechanisms responsible for MH are the production of parathyroid hormone-related peptide by the tumor (PTHrp) (80% of cases), osteolytic cytokine production (20%) and excess of 1,25(OH)2vitamin D production (1%).Case report: We present the case of a ...